GSK plc Research and Development Expense
GSK plc (GSK) reported Research and Development Expense of GBP 7.53 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-06
| Period end | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | 7.53B GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 6.40B GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | 6.22B GBP 20-F · filed 2026-03-06 | |
| 2022-12-31 | 5.49B GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | 5.02B GBP 20-F · filed 2024-03-05 | 5.28B GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | 4.79B GBP 20-F · filed 2023-03-10 | 5.10B GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | 4.57B GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | 3.89B GBP 20-F · filed 2021-03-12 | |
| 2017-12-31 | 4.48B GBP 20-F · filed 2020-03-06 | |
| 2016-12-31 | 3.63B GBP 20-F · filed 2019-03-15 | |
| 2015-12-31 | 3.56B GBP 20-F/A · filed 2018-03-20 |